• News
  • Sport
  • TV
  • Radio
  • Education
  • TV Licences
  • Contact Us
No Result
View All Result
  • SOUTH AFRICA
  • POLITICS
  • BUSINESS
  • SPORT
  • AFRICA
  • WORLD
  • SCI-TECH
  • LIFESTYLE
  • FEATURES
  • OPINION
Home Sci-tech

SAHPRA voices cautious optimism about Pfizer/BioNTech vaccine efficacy 

17 March 2021, 10:55 AM  |
SABC SABC |  @SABCNews
South Africa secured 20 million doses of the Pfizer/BioNTech vaccine which are expected in the country at the end of the month.

South Africa secured 20 million doses of the Pfizer/BioNTech vaccine which are expected in the country at the end of the month.

Image: Reuters

South Africa secured 20 million doses of the Pfizer/BioNTech vaccine which are expected in the country at the end of the month.

The South African Health Products Authority (SAHPRA) has voiced cautious optimism over the efficacy of the Pfizer/BioNTech vaccine against new variants of the coronavirus.

South Africa has secured 20 million doses of the vaccine, a batch of which are expected in the country from the end of next month.

The health product regulator says the approval of the jab is subject to further efficacy and safety surveillance. It has also approved a Section-21 emergency use application of the Pfizer/BioNTech shot.

SAHPRA’s Chairperson is Professor Helen Rees explains: “Our feeling is because this is such an effective vaccine that we are pretty confident that it is going to work, if not as well against the original, that it is going to work. Having said that, however, we are working with Pfizer and the other vaccine manufacturers and they are producing from the lab, data that shows the effectiveness. So we are very optimistic that it is going to work, particularly against severe disease.”

SAHPRA approves Section 21 emergency use application for the Pfizer-BioNTech vaccine

Rollout

SAHPRA has suggested that the national rollout of the Pfizer/BioNTech vaccine should begin as soon as the doses arrive in the country.

Rees adds, “I think the aim would be, as soon as we get these vaccines, the Department of Health and all the provinces are geared up to roll this out and as soon as we can get them in, into the airport and ship them out, we should start this rollout…”

“We want to go as fast we can but to be fair as well, even countries like Rwanda didn’t go fast to begin with. They had to get everything into gear and once you have done that then rollouts become much more straightforward,” says Rees.

She added saying the SAHPRA hoped that the vaccines would be rolled out in the country in April.

In the Explainer below, we breakdown the South African government’s COVID-19 vaccine rollout strategy as the country gets ready to receive 1 million doses of the vaccine:

SAHPRA has approved the Section 21 application for Pfizer/Biontech Comirnaty Vaccine. This approval is subject to conducting a post Section 21 authorisation efficacy and safety surveillance of Comirnaty vaccine in South Africa

— SAHPRA (@SAHPRA1) March 16, 2021

Sale of AstraZeneca vaccine

Meanwhile, SAHPRA says the Health Department is in the process of ensuring the AstraZeneca vaccine is sold and transferred to other countries. South Africa halted the use of the AstraZeneca jab earlier this year due to concerns over its efficacy against the dominant 501Y.V2 variant.

Several other countries have halted the rollout of the jab, following reports of clots developing in a small number of recipients.

The European Medicines Agency has reiterated that there is no indication that the AstraZeneca vaccine causes blood clots.

Professor Helen Rees says, “The Department of Health is negotiating on the sale, but that is quite far advanced and I think there will be a transfer fairly soon to other countries. In terms of the blood clots, what you have to do when you get these sorts of reports is, is the benefit of the vaccine exceed any potential risks because the risks are so so small that the benefit of the vaccine is so huge. So that is the process that is on-going and it hasn’t been finalised yet. The suspensions are temporary.”

11 EU countries pause use of AstraZeneca:

Share article
Tags: Pfizer-BioNTechSouth AfricaVaccineHelen ReesSAHPRASouth African Health Products Regulatory Authority
Previous Post

‘Funding historical debt will create financial woes for universities’

Next Post

VIDEO: Mthokozisi Ntumba memorial service

Related Posts

Shell petrol station

Activist group accuses Shell of misleading investors on renewables

1 February 2023, 3:40 PM
Researchers studying the BCG vaccine for tuberculosis test samples in a laboratory run by South African biotech company TASK in Cape Town, South Africa, May 11, 2020.

SA admitted to a prestigious international science program

1 February 2023, 8:53 AM
File Image: Hospital bed in a ward.

Gauteng Health battles with surgical backlogs

1 February 2023, 6:10 AM
A member of the Incident Management Team coordinates the search for a radioactive capsule that was lost in transit by a contractor hired by Rio Tinto, at the Emergency Services Complex in Cockburn, Australia, in this undated handout photo. Department of Fire and Emergency Services.

Australian nuclear body joins search for missing radioactive capsule

31 January 2023, 10:13 AM
A man wearing a protective face mask walks past an illustration of a virus outside a regional science centre amid the coronavirus disease (COVID-19) outbreak, in Oldham, Britain August 3, 2020.

WHO maintains highest alert over COVID, but sees hope ahead

30 January 2023, 7:18 PM
FILE PHOTO: Smoke billows from the chimneys of Belchatow Power Station in Poland, Europe's biggest coal-fired power plant, in this May 7, 2009.

Prof Marwala urges leaders to address challenges posed by climate change

30 January 2023, 6:42 PM
Next Post

VIDEO: Mthokozisi Ntumba memorial service

Most Viewed

  • 24hrs
  • Week
  • Month
  • Registration at Unisa closes on Friday, but management says no need to panic
  • Gas leak shut, isolated in Pretoria North
  • King of Bacardi music ‘Vusi Ma R5’ killed in Soshanguve
  • Committee wants to halt planned demolition of North West hospital
  • Bapedi kingdom commemorates Kgosi Mampuru II, still hoping to find his remains
  • Parts of the Northern Cape to be exempted from rolling blackouts
  • VIDEO | St Benedict College’s Matric learner gets 11 distinctions
  • Limpopo matriculant from child-headed household attains diploma pass
  • Female circumcision practice thriving in Eastern Cape
  • Premier denies claims that KZN government spent millions on Mampintsha’s funeral
  • At least 10 people killed in Bhityi area, Eastern Cape
  • Manhunt for 20 suspects in KwaMashu shooting
  • Zimbabwean embassy in SA to launch bid for the return of Zimbabwean Exemption Permit holders
  • LIVE: EFF leader Julius Malema and bodyguard back in court
  • VIDEO: Jacob Zuma vs State Advocate Billy Downer, Karen Maughan

LATEST

View of the Council Chambers for Ekurhuleni Metro
  • Politics

ANC accuses DA of using delay tactics in Ekurhuleni


Zimbabwean flag
  • Africa

Helping Zimbabwean permit holders not a political ploy: Ambassador


Electricity pylons  in South Africa.
  • Eskom rolling blackouts
  • Business

Eskom anticipates lower stages of load shedding by the weekend


File: An overview of the Niger delta where signs of oil spills can be seen in the water in Port Harcourt, Nigeria
  • Africa

Nigerian communities file damages claim against Shell


Crime scene image
  • South Africa

Police investigators still at scene of KwaMashu fatal shooting


Eskom logo against an electric bulb
  • Eskom rolling blackouts
  • Business

Key priority areas identified to fix energy crisis: Eskom board


Weather

  • About the SABC
  • Contact Us
  • Jobs
  • Advertise
  • Disclaimer
  • Site Map

SABC © 2023

No Result
View All Result
  • SOUTH AFRICA
  • POLITICS
  • BUSINESS
  • SPORT
  • AFRICA
  • WORLD
  • SCI-TECH
  • LIFESTYLE
  • FEATURES
  • OPINION

© 2022

Previous Wits protest ‘Funding historical debt will create financial woes for universities’
Next VIDEO: Mthokozisi Ntumba memorial service